SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to third-quarter FY20 financials, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Corporate Action-Board approves Dividend
As per letter attached 
Sun Pharma launches severe nodular acne management capsules in US
The product launched by company's wholly owned subsidiaries for the management of severe recalcitrant nodular acne in patients of 12 years of age and older, it can be taken with or without food, Sun Pharma said in a filing to BSE. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to ABSORICA LD(tm) (isotretinoin) capsules for management of severe recalcitrant nodular acne in the US, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,
Sun Pharma share price slips 1% on weak Q3 show by US subsidiary
Operating income shed 26.3 percent at USD 58.19 million and operating margin was at 39.4 percent versus 44.7 percent, YoY. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Corporate Action-Board to consider Dividend
Sub: Prior intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that the Board of Directors of the Company, at its meeting scheduled on Thursday, February 6, 2020, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the Financial Year 2019-2020. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificates/request for issue of duplicate share certificate reported by shareholders of the Company, received from our Registrar and Transfer Agent, Link Intime India Private Limited on January 29, 2020. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Loss of Share Certificate / Issue of Duplicate Share Certificate.
Sun Pharma recalls batches of anti-migraine drug, testosterone injection in US
The recall of sumatriptan succinate was started last month, while that of testosterone cypionate was initiated last week, as per US FDA data.Testosterone cypionate was manufactured by Sun Pharma at one of the company's plants in Gujarat